Messages from Kennichi Kakudo, MD, PhD to a person to be an expert of the cytopathology

IAC Webinar (Thyroid Nodule Practice: Asian Perspectives Reducing Overdiagnosis and Overtreatment) was over and its video is available at the following link: https://vimeo.com/1175151147/fa398a7c21?fl=tl&fe=ec  

Dear colleagues and visitors to our website,

I will be presenting at the IAC Webinar on March 19, 2026, entitled:

“Thyroid Nodule Practice: Asian Perspectives — Reducing Overdiagnosis and Overtreatment.”

For further details about the webinar, please visit:
https://www.cytology-iac.org/members-area/iac-webinar-19-march-2026/

It appears that participation is open not only to IAC members but also to non-members.
However, registration is required. Pre-registration can be completed through the link above.

I look forward to your participation.

Sincerely,
Kennichi Kakudo

Professor Zhiyan Liu, chairman, department of pathology, Shanghai Sixth People’s Hospital affiliated to Shanghai Jiao Tong University School of Medicine, held the 7^th Thyroid Pathology Congress in Shanghai, The first day program is attached. I participated with my lecture on papillary thyroid carcinoma in the 5^thedition WHO classification.

From June 19–22, I attended the ITC in Rio de Janeiro. Brazil was especially memorable for me, as opportunities to attend conferences there are rare. Before the meeting, I traveled to the Amazon, Brazil and then to Machu Picchu in Chile—truly remarkable experiences. At the ITC, I spoke on “Indeterminate Thyroid Nodule Practices in Asia”(photo 1). Of course, Rio de Janeiro itself offered many wonderful sightseeing opportunities

.

The Asian Thyroid Working Group conducted a symposium in the AOTA Bali held on May 23rd, 2024. Dr. Liu, Hang, Jung and Bychkov jointed it as speakers and Dr. Lai and I chaired it (Fig. 1) . In a same time the Department of Pathology, University of Indonesia invited us for lectures before and after the AOTA meeting. I had an opprtunity to deliver my lecture on overdiagnosis and overtreatment of cancer together with Dr. Tsujinaka (Fig. 2).